Investor · LEXINGTON, MA

Jason Coloma

Open Jason in the network graph →

Filings

5

SEC Form D

Connections

35

co-filers

Capital

$384.2M

across filings

Active

Apr 2021

to Apr 2024

Most-connected co-filers (35)

Jason Camm · Cambridge, MA2 shared Alex Kolicich · SAN FRANCISCO, CA2 shared Fabian B. Hansen · LEXINGTON, MA2 shared Errik B. Anderson · LEXINGTON, MA2 shared Logan B. Snyder · LEXINGTON, MA2 shared Ulrik B. Nielsen · CAMBRIDGE, MA2 shared Piotr B. Bobrowicz · LEXINGTON, MA2 shared Kouki Harasaki · San Francisco, CA1 shared Joey Mure · BIRMINGHAM, AL1 shared Russell Morgan · Birmingham, AL1 shared Rishi Kumar · NEW YORK, NY1 shared Anil Arora · New York, NY1 shared Jeffrey Lesage · Manhattan Beach, CA1 shared Seiji Miyahara · San Mateo, CA1 shared Ann Lee-Karlon · San Mateo, CA1 shared Rehka Hemrajani · Richmond, CA1 shared Kristen Fortney · Richmond, CA1 shared Eric Morgen · Richmond, CA1 shared Ali S. Farahanchi · Cambridge, MA1 shared Chuck S. Carignan · Cambridge, MA1 shared Alaa Halawa · Watertown, MA1 shared Anthony B. Sun · WALTHAM, MA1 shared Samuel Bjork · Seattle, WA1 shared Jay B. Rosanelli · LEXINGTON, MA1 shared

Recent filings (5)

EpiBiologics, Inc.Apr 2024 · 16 co-filers$73.0M EpiBiologics, Inc.Apr 2024 · 16 co-filers$73.0M BioAge Labs, Inc.Feb 2024 · 15 co-filers$194.4M BioAge Labs, Inc.Feb 2024 · 15 co-filers$194.4M SURGE Therapeutics, Inc.Jun 2023 · 13 co-filers$50.0M SURGE Therapeutics, Inc.Jun 2023 · 13 co-filers$50.0M Alloy Therapeutics, Inc.Oct 2022 · 19 co-filers$41.7M Alloy Therapeutics, Inc.Oct 2022 · 19 co-filers$41.7M Alloy Therapeutics, Inc.Apr 2021 · 17 co-filers$75.0M Alloy Therapeutics, Inc.Apr 2021 · 17 co-filers$75.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Jason in the interactive graph →